Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Wellcome Trust has awarded a two-year extension to the grant for our Wellcome Centre for Integrative Neuroimaging. This means that WIN is funded through to April 2024.

Group of researchers from Wellcome Centre for Integrative Neuroimaging

The Wellcome Centre for Integrative Neuroimaging (WIN) was established in 2017. It bridges the gap between laboratory neuroscience and human health, by performing multi-scale studies spanning from animal models through to human populations.

The extension is testament to the progress that WIN has demonstrated so far against its vision in all five of its themes: cross-species relationships; cross-scale integration; population data-mining; clinical neuroimaging and open neuroimaging.

WIN researchers have so far generated 698 peer-reviewed publications (and 152 preprints). These papers have collectively gathered 4807 citations to date.

The work of WIN staff has had an impact in many areas, including:

  • Clinical discovery (e.g. throuh the licensing of its software library (FSL) to non-academic users in clinical settings)
  • Clinical practice (e.g. establishing the ‘Brain Health Centre’, opening to memory clinic patients in spring 2020)
  • Engaging industry (e.g. hosting five industry-funded PhD students)
  • Scientific practice: (e.g. influencing neuroimaging research practice via FSL. The main FSL paper has been cited >9000 times).
  • Public debate (e.g. holding a day for patients and public on ‘Building better brain research’).

WIN has also had an impact more locally, initiating new collaborations and leveraging further funding. Fifty-three PhD students have completed since WIN began, and facilities have been enhanced (including the installation of a new rodent scanner and a new MEG scanner).

WIN has ensured that working practices reflect its values, including openness and inclusivity. For example, they have established working groups in Open Science and Equality, Diversity and Inclusion.

Core staff have been recruited, including Jason Lerch (heading up the small-animal imaging facility), Ben Seymour (Wellcome Clinical Research Fellow) and Madalena Fonseca (preclinical functional MRI).

The extension will allow WIN to establish incentives (e.g seed grants) and support (e.g facilitators) for projects that take mechanism to clinical population, or basic neuroscience to clinical translation. It will also provide resources to develop their cutting-edge work on building a positive research culture.

Similar stories

NICE recommends offering app-based treatment for people with insomnia instead of sleeping pills

Hundreds of thousands of people suffering from insomnia who would usually be prescribed sleeping pills could be offered an app-based treatment programme instead, NICE has said.

Developmental dynamics of the neural crest–mesenchymal axis in creating the thymic microenvironment

A new paper from researchers at the Department of Paediatrics and the Nuffield Department of Clinical Neurosciences has shown that fibroblasts in the thymus, often considered simply as dull “structural” cells, are much more complex than previously thought.

How to use the science of the body clock to improve our sleep and health

Professor Russell Foster has written a new book about circadian neuroscience which is published by Penguin this week. This book review by Jacqueline Pumphrey was first published on the University of Oxford website.

Funding awarded for autoimmune disease research

Dr Kate Attfield awarded project funding by Connect Immune Research and The Lorna and Yuti Chernajovsky Biomedical Research Foundation.

Oxford researchers part of major UK initiative to understand chronic pain

Oxford pain researchers are playing a major role in a new multi-million pound research programme launched by a consortium of funders, including UKRI, Versus Arthritis, Eli Lilly and the Medical Research Foundation.